Polycystic ovary syndrome with hyperandrogenism is characterized by an increased risk of hepatic steatosis compared to nonhyperandrogenic PCOS phenotypes and healthy controls, independent of obesity and insulin resistance - Jones, H; Sprung, V S; Pugh, C J (J Clin Endocrinol Metab, 2012)
, et al.